Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Autoantibodies | 25 | 2021 | 474 | 6.040 |
Why?
|
Receptors, Adrenergic, beta-1 | 9 | 2019 | 22 | 3.050 |
Why?
|
Polycystic Ovary Syndrome | 4 | 2021 | 65 | 2.240 |
Why?
|
Receptors, Adrenergic, beta-2 | 8 | 2014 | 23 | 2.140 |
Why?
|
Postural Orthostatic Tachycardia Syndrome | 4 | 2021 | 9 | 2.080 |
Why?
|
Receptor, Angiotensin, Type 1 | 5 | 2018 | 11 | 1.740 |
Why?
|
Receptor, Muscarinic M2 | 5 | 2021 | 15 | 1.210 |
Why?
|
Hypotension, Orthostatic | 3 | 2013 | 8 | 1.190 |
Why?
|
Receptors, LHRH | 4 | 2021 | 17 | 1.130 |
Why?
|
Insulin Resistance | 3 | 2021 | 175 | 1.060 |
Why?
|
Autoimmunity | 3 | 2018 | 157 | 1.020 |
Why?
|
Heart Rate | 5 | 2021 | 379 | 0.940 |
Why?
|
Immunoglobulin G | 7 | 2013 | 270 | 0.940 |
Why?
|
Arrhythmias, Cardiac | 2 | 2015 | 163 | 0.850 |
Why?
|
Atrial Fibrillation | 5 | 2015 | 402 | 0.850 |
Why?
|
Rabbits | 8 | 2019 | 276 | 0.850 |
Why?
|
Animals | 25 | 2021 | 10415 | 0.760 |
Why?
|
Vasoconstriction | 4 | 2018 | 45 | 0.750 |
Why?
|
Posture | 2 | 2019 | 39 | 0.740 |
Why?
|
Muscarinic Antagonists | 1 | 2021 | 14 | 0.740 |
Why?
|
Hypertension | 4 | 2015 | 308 | 0.730 |
Why?
|
Myocardial Infarction | 4 | 2009 | 346 | 0.700 |
Why?
|
Proteasome Inhibitors | 3 | 2009 | 26 | 0.700 |
Why?
|
Graves Disease | 3 | 2015 | 8 | 0.700 |
Why?
|
Peptide Fragments | 2 | 2019 | 202 | 0.700 |
Why?
|
Disease Models, Animal | 6 | 2019 | 1459 | 0.690 |
Why?
|
Tachycardia | 3 | 2015 | 72 | 0.680 |
Why?
|
Peptides | 3 | 2021 | 288 | 0.660 |
Why?
|
Heart Diseases | 2 | 2010 | 70 | 0.620 |
Why?
|
Proteasome Endopeptidase Complex | 3 | 2009 | 80 | 0.610 |
Why?
|
Hyperaldosteronism | 3 | 2014 | 3 | 0.610 |
Why?
|
Blood Pressure | 2 | 2019 | 354 | 0.570 |
Why?
|
Receptors, Adrenergic, beta | 3 | 2011 | 24 | 0.530 |
Why?
|
Vasodilator Agents | 2 | 2013 | 79 | 0.510 |
Why?
|
Thyroxine | 1 | 2015 | 11 | 0.500 |
Why?
|
Adrenergic beta-1 Receptor Antagonists | 1 | 2015 | 5 | 0.500 |
Why?
|
Heart Atria | 2 | 2015 | 175 | 0.480 |
Why?
|
Vasodilation | 3 | 2014 | 114 | 0.470 |
Why?
|
Obesity | 1 | 2021 | 669 | 0.470 |
Why?
|
Tachycardia, Ventricular | 2 | 2005 | 60 | 0.470 |
Why?
|
Rats | 7 | 2021 | 1576 | 0.460 |
Why?
|
Female | 17 | 2021 | 15153 | 0.450 |
Why?
|
Tachycardia, Supraventricular | 1 | 2014 | 23 | 0.450 |
Why?
|
Thyroid Hormones | 1 | 2014 | 36 | 0.440 |
Why?
|
Male | 20 | 2019 | 13489 | 0.430 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2013 | 33 | 0.430 |
Why?
|
Ubiquitin | 2 | 2009 | 24 | 0.400 |
Why?
|
Humans | 22 | 2021 | 28094 | 0.400 |
Why?
|
Receptor, Muscarinic M3 | 1 | 2012 | 4 | 0.380 |
Why?
|
Receptors, Muscarinic | 1 | 2011 | 9 | 0.380 |
Why?
|
Antibodies, Monoclonal | 1 | 2013 | 329 | 0.370 |
Why?
|
Arterioles | 4 | 2015 | 61 | 0.340 |
Why?
|
Protease Inhibitors | 2 | 2009 | 40 | 0.340 |
Why?
|
Cardiomyopathies | 2 | 2008 | 33 | 0.340 |
Why?
|
Adrenergic beta-Agonists | 2 | 2010 | 19 | 0.320 |
Why?
|
Cytokines | 2 | 2021 | 447 | 0.300 |
Why?
|
Myocardial Ischemia | 2 | 2008 | 73 | 0.300 |
Why?
|
Cushing Syndrome | 1 | 2007 | 4 | 0.280 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2015 | 257 | 0.270 |
Why?
|
Diabetic Angiopathies | 1 | 2007 | 48 | 0.260 |
Why?
|
Middle Aged | 11 | 2014 | 7137 | 0.260 |
Why?
|
Critical Illness | 1 | 2007 | 66 | 0.260 |
Why?
|
Dogs | 7 | 2010 | 509 | 0.260 |
Why?
|
Renin | 2 | 2005 | 3 | 0.260 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2007 | 97 | 0.250 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2009 | 117 | 0.240 |
Why?
|
Renal Artery Obstruction | 1 | 2005 | 4 | 0.240 |
Why?
|
Rats, Sprague-Dawley | 2 | 2021 | 551 | 0.240 |
Why?
|
Renal Artery | 1 | 2005 | 15 | 0.240 |
Why?
|
Adult | 9 | 2018 | 7739 | 0.230 |
Why?
|
Aged | 7 | 2014 | 5400 | 0.230 |
Why?
|
Biological Assay | 3 | 2021 | 34 | 0.230 |
Why?
|
Blood Glucose | 2 | 2021 | 309 | 0.220 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2005 | 247 | 0.210 |
Why?
|
Postoperative Complications | 1 | 2007 | 611 | 0.190 |
Why?
|
Epitopes | 2 | 2021 | 183 | 0.190 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2013 | 66 | 0.190 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2021 | 18 | 0.180 |
Why?
|
Glucose Transporter Type 2 | 1 | 2021 | 4 | 0.180 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2021 | 23 | 0.180 |
Why?
|
Testosterone | 1 | 2021 | 72 | 0.180 |
Why?
|
Glucose Transporter Type 4 | 1 | 2021 | 62 | 0.170 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2021 | 135 | 0.170 |
Why?
|
Autoimmune Diseases | 2 | 2014 | 164 | 0.160 |
Why?
|
G-Protein-Coupled Receptor Kinase 2 | 2 | 2009 | 7 | 0.160 |
Why?
|
Young Adult | 3 | 2018 | 2732 | 0.160 |
Why?
|
Adipose Tissue | 1 | 2021 | 183 | 0.160 |
Why?
|
Hemodynamics | 2 | 2014 | 220 | 0.160 |
Why?
|
Immunization | 1 | 2019 | 120 | 0.160 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2013 | 331 | 0.150 |
Why?
|
Cricetinae | 3 | 2014 | 129 | 0.150 |
Why?
|
Treatment Outcome | 2 | 2015 | 2377 | 0.150 |
Why?
|
Signal Transduction | 2 | 2015 | 1435 | 0.140 |
Why?
|
Losartan | 2 | 2014 | 4 | 0.140 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 2 | 2014 | 8 | 0.140 |
Why?
|
Cricetulus | 2 | 2014 | 56 | 0.130 |
Why?
|
CHO Cells | 2 | 2014 | 96 | 0.130 |
Why?
|
Death, Sudden, Cardiac | 2 | 2008 | 28 | 0.130 |
Why?
|
Adolescent | 3 | 2018 | 3121 | 0.130 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 634 | 0.130 |
Why?
|
Adrenergic beta-1 Receptor Agonists | 1 | 2015 | 4 | 0.130 |
Why?
|
Muscarinic Agonists | 1 | 2015 | 9 | 0.130 |
Why?
|
Coronary Sinus | 1 | 2015 | 4 | 0.130 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2014 | 607 | 0.130 |
Why?
|
Refractory Period, Electrophysiological | 1 | 2015 | 21 | 0.120 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 2015 | 2 | 0.120 |
Why?
|
Antibodies, Blocking | 1 | 2015 | 3 | 0.120 |
Why?
|
Case-Control Studies | 3 | 2014 | 722 | 0.120 |
Why?
|
Purkinje Fibers | 3 | 2010 | 37 | 0.120 |
Why?
|
Antigens | 1 | 2015 | 67 | 0.120 |
Why?
|
Biomimetic Materials | 1 | 2015 | 20 | 0.120 |
Why?
|
Electrocardiography | 3 | 2008 | 394 | 0.120 |
Why?
|
Angiotensin II | 1 | 2015 | 55 | 0.120 |
Why?
|
Atropine | 2 | 2012 | 47 | 0.120 |
Why?
|
Up-Regulation | 1 | 2015 | 246 | 0.110 |
Why?
|
Propranolol | 2 | 2012 | 39 | 0.110 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2015 | 131 | 0.110 |
Why?
|
Heart Conduction System | 1 | 2015 | 270 | 0.110 |
Why?
|
Receptors, Adrenergic | 1 | 2014 | 10 | 0.110 |
Why?
|
Captopril | 2 | 2005 | 9 | 0.110 |
Why?
|
Myocardium | 2 | 2005 | 192 | 0.110 |
Why?
|
Propanolamines | 1 | 2013 | 16 | 0.110 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 207 | 0.110 |
Why?
|
Acetylcholine | 1 | 2013 | 73 | 0.110 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2014 | 77 | 0.110 |
Why?
|
Surface Plasmon Resonance | 1 | 2013 | 37 | 0.110 |
Why?
|
Myocytes, Cardiac | 1 | 2013 | 61 | 0.100 |
Why?
|
Endoplasmic Reticulum Stress | 1 | 2013 | 39 | 0.100 |
Why?
|
Autophagy | 1 | 2013 | 73 | 0.100 |
Why?
|
Muscle Contraction | 1 | 2014 | 170 | 0.100 |
Why?
|
Aorta | 1 | 2013 | 124 | 0.100 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 250 | 0.100 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2012 | 96 | 0.100 |
Why?
|
Ligation | 3 | 2008 | 39 | 0.100 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 3 | 2008 | 33 | 0.090 |
Why?
|
Cardiac Myosins | 2 | 2008 | 17 | 0.090 |
Why?
|
Electrophysiology | 3 | 2008 | 150 | 0.090 |
Why?
|
Models, Animal | 1 | 2012 | 129 | 0.090 |
Why?
|
Comorbidity | 1 | 2012 | 258 | 0.090 |
Why?
|
Mitochondria | 1 | 2013 | 369 | 0.080 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 1319 | 0.080 |
Why?
|
Boronic Acids | 2 | 2008 | 9 | 0.080 |
Why?
|
Bortezomib | 2 | 2008 | 22 | 0.080 |
Why?
|
Pyrazines | 2 | 2008 | 24 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2009 | 70 | 0.080 |
Why?
|
Syndrome | 2 | 2007 | 78 | 0.080 |
Why?
|
Inflammation | 1 | 2013 | 636 | 0.080 |
Why?
|
Oxidative Stress | 1 | 2013 | 668 | 0.080 |
Why?
|
NF-kappa B | 1 | 2009 | 191 | 0.080 |
Why?
|
Myocarditis | 1 | 2008 | 21 | 0.070 |
Why?
|
G-Protein-Coupled Receptor Kinase 3 | 1 | 2008 | 8 | 0.070 |
Why?
|
Adrenocortical Hyperfunction | 1 | 2007 | 3 | 0.070 |
Why?
|
Aminoglutethimide | 1 | 2007 | 3 | 0.070 |
Why?
|
Drug Administration Routes | 1 | 2007 | 8 | 0.070 |
Why?
|
Itraconazole | 1 | 2007 | 9 | 0.070 |
Why?
|
Gastroplasty | 1 | 2007 | 5 | 0.070 |
Why?
|
Streptozocin | 1 | 2007 | 11 | 0.070 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 2007 | 11 | 0.070 |
Why?
|
Multienzyme Complexes | 1 | 2007 | 29 | 0.070 |
Why?
|
Mitochondria, Heart | 1 | 2007 | 23 | 0.070 |
Why?
|
Blotting, Western | 2 | 2008 | 514 | 0.070 |
Why?
|
Dexamethasone | 1 | 2007 | 63 | 0.070 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2007 | 64 | 0.070 |
Why?
|
Glucocorticoids | 1 | 2007 | 115 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 225 | 0.060 |
Why?
|
Body Weight | 1 | 2007 | 250 | 0.060 |
Why?
|
G-Protein-Coupled Receptor Kinase 5 | 1 | 2005 | 3 | 0.060 |
Why?
|
Diuresis | 1 | 2005 | 5 | 0.060 |
Why?
|
Pulmonary Veins | 1 | 2006 | 108 | 0.060 |
Why?
|
Furosemide | 1 | 2005 | 7 | 0.060 |
Why?
|
Renal Veins | 1 | 2005 | 7 | 0.060 |
Why?
|
Diuretics | 1 | 2005 | 12 | 0.060 |
Why?
|
Angiography | 1 | 2005 | 35 | 0.060 |
Why?
|
Radionuclide Imaging | 1 | 2005 | 56 | 0.060 |
Why?
|
Autonomic Nervous System | 1 | 2006 | 112 | 0.060 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 32 | 0.060 |
Why?
|
beta-Adrenergic Receptor Kinases | 1 | 2005 | 7 | 0.060 |
Why?
|
Etanercept | 1 | 2005 | 6 | 0.060 |
Why?
|
Pericardium | 1 | 2005 | 47 | 0.060 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2005 | 18 | 0.060 |
Why?
|
Neutrophil Infiltration | 1 | 2005 | 19 | 0.060 |
Why?
|
Microscopy, Confocal | 1 | 2005 | 113 | 0.060 |
Why?
|
Immunoblotting | 1 | 2005 | 124 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 328 | 0.060 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 163 | 0.060 |
Why?
|
Oxygen Consumption | 1 | 2005 | 181 | 0.050 |
Why?
|
Kidney | 1 | 2005 | 286 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 1 | 2007 | 819 | 0.050 |
Why?
|
Mice, Inbred C57BL | 1 | 2007 | 1574 | 0.050 |
Why?
|
Child, Preschool | 1 | 2005 | 1146 | 0.050 |
Why?
|
Follicular Atresia | 1 | 2021 | 4 | 0.050 |
Why?
|
Luteinizing Hormone | 1 | 2021 | 57 | 0.040 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2021 | 37 | 0.040 |
Why?
|
Myocardial Contraction | 2 | 2009 | 62 | 0.040 |
Why?
|
Mice | 1 | 2007 | 4650 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2014 | 2021 | 0.030 |
Why?
|
Coronary Vessels | 2 | 2008 | 152 | 0.030 |
Why?
|
Adrenergic Agonists | 1 | 2014 | 6 | 0.030 |
Why?
|
Receptors, Adrenergic, alpha-1 | 1 | 2014 | 6 | 0.030 |
Why?
|
Tennessee | 1 | 2014 | 27 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2014 | 463 | 0.030 |
Why?
|
Transfection | 1 | 2014 | 318 | 0.030 |
Why?
|
Prevalence | 1 | 2014 | 497 | 0.030 |
Why?
|
Biomarkers | 1 | 2014 | 765 | 0.020 |
Why?
|
Oklahoma | 1 | 2014 | 1007 | 0.020 |
Why?
|
Adrenergic beta-2 Receptor Antagonists | 1 | 2008 | 4 | 0.020 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2008 | 19 | 0.020 |
Why?
|
Cross Reactions | 1 | 2008 | 72 | 0.020 |
Why?
|
HSP72 Heat-Shock Proteins | 1 | 2008 | 3 | 0.020 |
Why?
|
Chymotrypsin | 1 | 2008 | 4 | 0.020 |
Why?
|
Catecholamines | 1 | 2008 | 18 | 0.020 |
Why?
|
Trypsin | 1 | 2008 | 24 | 0.020 |
Why?
|
Pheochromocytoma | 1 | 2007 | 9 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2007 | 56 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2007 | 56 | 0.020 |
Why?
|
Reference Values | 1 | 2007 | 199 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2007 | 114 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2008 | 137 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 689 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 1051 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 371 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2007 | 123 | 0.020 |
Why?
|
Aldosterone | 1 | 2002 | 4 | 0.010 |
Why?
|
Time Factors | 1 | 2006 | 1591 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2002 | 2546 | 0.010 |
Why?
|